Thus, we initiated the current study to definitively ask if altered VEGF expression and downregulation of angiogenesis were the key effects of mTOR inhibitors that mediated tumor cell apoptosis and tumor rejection in vivo. This evidence concerns the gene VEGFA and neoplasm.